- Home
- PHVS vs ASGN Comparison
PHVS vs ASGN Comparison
Compare PHVS & ASGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHVS | ASGN |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PHVS | ASGN |
|---|---|---|
| Price | $31.63 | $19.58 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 11 | 7 |
| Target Price | ★ $41.82 | $38.43 |
| AVG Volume (30 Days) | 319.5K | ★ 9.7M |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $3,980,400,000.00 |
| Revenue This Year | N/A | $3.26 |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | ★ N/A | $150.62 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.00 | $19.31 |
| 52 Week High | $33.33 | $60.06 |
Technical Indicators
Market Signals| Indicator | PHVS | ASGN |
|---|---|---|
| Relative Strength Index (RSI) | 60.03 | 18.34 |
| Support Level | $24.55 | N/A |
| Resistance Level | $33.33 | $47.94 |
| Average True Range (ATR) | 1.27 | 1.84 |
| MACD | 0.02 | -0.85 |
| Stochastic Oscillator | 99.41 | 1.21 |
Price Performance
Historical ComparisonAbout PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.